Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cynosure Inc (NASDAQ:CYNO)

48.37
Delayed Data
As of May 27
 +0.59 / +1.23%
Today’s Change
29.00
Today|||52-Week Range
51.59
+8.28%
Year-to-Date

Today’s Trading

Previous close47.78
Today’s open47.67
Day’s range47.67 - 48.94
Volume243,902
Average volume (3 months)297,116
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-50.35%
Earnings growth (this year)+19.14%
Earnings growth (next 5 years)+19.30%
Revenue growth (last year)+16.11%
P/E ratio59.7
Price/Sales2.98
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
CNMDConmed Corp+0.41+1.05%
XLRNAcceleron Pharma Inc-0.46-1.34%
MDXGMiMedx Group Inc+0.17+2.19%
SPNCSpectranetics Corp+0.31+1.71%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.29
Annual revenue (last year)$339.5M
Annual profit (last year)$15.8M
Net profit margin4.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Davin
Secretary, Senior Vice President &
General Counsel
Peter C. Anastos
Corporate headquarters
Westford, Massachusetts

Forecasts

Partner Offers

Search for Jobs